| Website | sanderling.com |
| Phone | 650-401-2000 |
| Employees | |
| Founded | 1979 |
| Description | Oldest investment firms |
Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. Sanderling demonstrates that significant companies are best built in close working partnerships with entrepreneurs.Sanderling’s unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates-of-return for both its entrepreneurs and investors. Biomedical investing has been a viable sector in the technology markets for more than thirty years, and in the past ten years has experienced accelerated growth. Since its inception, Sanderling has supported over 60 biomedical companies from very early stages through commercial development, earning consistently high rates-of-return on its venture investments.
| Company | Date | Round | Size | Participants |
| Trinity Biosystems | 11/09 | Unattributed | $7.5M | 5 |
| Chimerix | 8/09 | Series E | $16.1M | 4 |
| Axikin Pharmaceuticals | 1/09 | Series A | $3M | 2 |
| CalciMedica | 1/09 | Series C | $4M | 3 |
| Actimis Pharmaceuticals | 6/08 | Unattributed | $9.6M | 1 |
| Asteres | 6/08 | Unattributed | $4M | 1 |
| Triage Wireless | 3/08 | Series B | $20.3M | 4 |
| Taligen Therapeutics | 1/08 | Series B | $65M | 4 |
| Asteres | 11/07 | Series C | $4M | 3 |
| Chimerix | 11/04 | Series C | $11M | 3 |
